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ABSTRACT
CONTEXT AND OBJECTIVE: Inadequate Pap smears do not provide satisfactory cell samples for evalua-
tion, thus making it more difficult to detect cervical cytological abnormalities. The objective of this study 
was to determine the cytological and histological follow-up results from women with inadequate smear 
reports in primary healthcare centers in Santiago, Chile 2010-2011. 
DESIGN AND SETTING: Prospective cohort study at primary healthcare clinics in Santiago, Chile.
METHODS: The population was taken from the “Cito-Expert” database of 2010. The data were then or-
ganized according to the cytological and histological follow-up results of 2,547 women with inadequate 
cervical cytological reports over the 12-month period. The samples were assigned to groups based on 
the cause of inadequacy (smears with endocervical cells alone; insufficient, hemorrhagic, inflammatory or 
poorly fixed samples; insufficient and hemorrhagic samples; or insufficient and inflammatory specimens). 
The data were analyzed using the “conditional probability tree diagram” and descriptive statistics.
RESULT: Half of the women (n = 1,285) met the requirements of the Ministry of Health for repeating these 
inadequate smears, and 1,104 of these women had normal cytological results (85.9%). The detection rate 
for cervical lesions according to group ranged from 0% (smears with endocervical cells alone or insuf-
ficient and hemorrhagic specimens) to 4.1% (poor fixation). 
CONCLUSION: The large proportion of normal results justifies revision of the current clinical guidelines. 
The results showed that it is not necessary to repeat the Pap test early on, with the exception of inadequate 
hemorrhagic and inflammatory cytological results. 
RESUMO
CONTEXTO E OBJETIVO: Esfregaços inadequados de Papanicolaou não fornecem amostra satisfatória de 
células para avaliação, ficando assim mais difícil detectar anomalias citológicas cervicais. O objetivo deste 
estudo foi determinar os resultados de seguimento citológico e histológico de mulheres com relatórios de 
esfregaços inadequados nas unidades básicas de saúde em Santiago, Chile, 2010-2011.
DESENHO E LOCAL: Estudo prospectivo de coorte em unidades básicas de saúde em Santiago, Chile. 
MÉTODOS: A população foi selecionada do banco de dados Cito-Expert em 2010. Na sequência, os 
dados foram organizados pelos resultados de seguimento citológico e histológico de 2.547 mulheres 
com relatórios inadequados de citologia cervical pelo período de 12 meses. As amostras foram atri-
buídas a grupos com base na causa de inadequação (esfregaços com células endocervicais; amostras 
insuficientes, inflamatórias, ou com má fixação, amostras insuficientes e hemorrágicas, ou espéci-
mes insuficientes e inflamatórios). Os dados foram analisados com base no “conditional probability 
tree diagram” e estatísticas descritivas. 
RESULTADOS: Metade das mulheres (n = 1.285) preencheram os requisitos do Ministério da Saúde para 
repetir esses esfregaços; dessas mulheres, 1.104 tiveram resultados normais para citologia (85,9%). A detec-
ção de lesões cervicais por grupo variou de 0% (esfregaços com apenas células endocervicais e espécimes 
insuficientes e hemorrágicos) para 4,1% (má fixação). 
CONCLUSÃO: Uma grande proporção de resultados normais justifica a revisão das diretrizes clínicas atuais. 
Os resultados mostraram que não é necessário repetir tão cedo o teste de Papanicolaou, exceto em resul-
tados inadequados de hemorragia e citologia inflamatória.
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INTRODUCTION
Inadequate Pap smears are those that do not provide satisfactory cell 
samples for evaluation, thus making it more difficult to detect cervi-
cal cytological abnormalities and making it necessary to repeat the 
test, according to the current requirements of the National Cervical 
Cancer Research and Control Program in Chile.1,2 Trained profes-
sionals (midwives or gynecologists) are involved in this process. 
They are guided by regulations that establish uniform criteria for 
the patient’s prior clinical condition and for applying the conven-
tional technique for collecting cervical cytology smears.1 The diag-
nostic codes of the Chilean National Program are used for reporting, 
and they are equivalent to the 2001 Bethesda System.3 These codes 
define the adequacy of cytological smears in categories that are con-
sidered to be satisfactory or unsatisfactory for evaluation. “Adequate 
samples” that are satisfactory for evaluation are classified as G8. 
“Inadequate samples” and their specific causes are classified between 
G0 and G7 and from G9 onwards.2
At the public health level, the relevance of inadequate Pap 
smears has been mentioned by Gonzalez et al., who stated that 
one of the main problems in the National Cervical Cancer 
Screening Program (NCCSP) in Mexico was inadequacy of cyto-
logical sampling.4 In this regard, Cendales et al. concluded that 
the quality of the cytological investigation is an important fac-
tor that can explain the low impact of the healthcare program 
on cervical cancer mortality in Colombia.5 Similarly, a report by 
Amaral et al. in Brazil suggested that inadequate cytological spec-
imens might contribute towards increased numbers of undiag-
nosed precursor lesions, thus affecting the morbidity and mor-
tality rates of cervical cancer.6 On the other hand, Adams et al. 
followed up cervical cytological smears, and the results indicated 
there was no difference between unsatisfactory and satisfactory 
smears with regard to the prevalence of the cervical lesions that 
were detected.7 These results were similar to those mentioned 
by Elumir-Tanner in their review.8 These findings challenge the 
notion that the Pap cytological test needs to be repeated after a 
period of 2-4 months, i.e. the practice suggested by the American 
Society for Colposcopy and Cervical Pathology, a standard that 
has been adopted by the Ministry of Health in Chile.1,9
OBJECTIVE
The objective of this study was to determine the cytohistological 
follow-up results from women attended within primary health-
care centers in the Southern Metropolitan Area of Santiago, Chile, 
in 2010-2011, whose cytological reports presented inadequacies.
METHODS
This was a descriptive, prospective, observational and quantitative 
epidemiological study based on following up cohorts of women 
with inadequate Pap test results that were reported within the 
National Cervical Cancer Research and Control Program in Chile. 
In 2010, 47,541 exfoliative cervical cytological smears were 
collected using the conventional Pap sampling technique by pro-
fessionals at primary healthcare (PHC) centers in the southern 
metropolitan area of Santiago, Chile. These smears were processed 
and classified in accordance with the national nomenclature, by 
the pathology department’s cytology laboratory at the Barros Luco 
Healthcare Complex, Santiago, Chile. The cytology reports were 
registered in the “Cito-Expert” national database. From this, all the 
inadequate Pap results from the 2010 period were selected, giving 
a total of 2,779 tests. This number corresponded to 5.84% of all the 
tests performed over the study period (2010). Evaluation of these 
inadequate specimens did not allow a positive or a negative cyto-
logical diagnostic description (Table 1).
Next, the women with inadequate results were selected, 
leaving a total population of 2,547. This population of women 
(n = 2,547) did not correspond to the number of tests (2,779), 
because some of the women had two inadequate Pap results. 
The women were then organized into cohorts according to 
the cause of the inadequate result: G0 (smears with endocervi-
cal cells alone), 4 women; G1 (insufficient sample), 375 women; 
G2 (hemorrhagic cells), 249 women; G3 (inflammatory cells), 
1,427 women; G4 (poor fixation), 61 women; G5 (insufficient 
and hemorrhagic samples), 40 women; G6 (insufficient and 
inflammatory samples), 391 women; G7 (endocervical and/or 
metaplasmic cells are not observed); and G9 (broken slide), none 
(Table  2). While preserving the participants’ anonymity, the 
information variables were the women’s ages at the time when 
Table 1. Distribution of exfoliative cervical cytological 
smears according to the adequacy of the sample, processed 
in the cytology laboratory at the Barros Luco Healthcare 
Complex, Santiago, Chile, 2010
Adequacy of cytological smears Number Percentage (%)
Satisfactory for evaluation 44,762 94.16
Unsatisfactory for evaluation 2,779 5.84
Total 47,541 100.00
Table 2. Distribution of women with inadequate cervical 
smear reports attended at primary healthcare centers in the 
southern metropolitan area of Santiago, Chile, 2010 
Reasons for inadequate Pap smears Number Percentage
Smears with endocervical cells only (G0) 4 0.2
Insufficient sample (G1) 375 14.7
Hemorrhagic sample (G2) 249 9.8
Inflammatory sample (G3) 1,427 56.0
Poor fixation (G4) 61 2.4
Insufficient and hemorrhagic sample (G5) 40 1.6
Insufficient and inflammatory sample (G6) 391 15.3
Endocervical and metaplasmic cells were  
not observed (G7)
0 0
Broken slide (G9) 0 0
Total 2,547 100.0
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the inadequate Pap smear was identified, the number and type of 
cytological and histological results and the length of follow-up 
(months), which ended with the diagnostic confirmation. 
This information was taken from the secondary source of the 
Cito-Expert cytological database.
The current requirements indicate that when an inadequate 
cytological result is obtained, the Pap test should be repeated 
after a three-month period. In the case of a normal Pap result, the 
test should be repeated after a three-year period, and when 
the results are pathological, the woman should be referred to the 
Cervical Pathology Unit. In the case of the present study, our fol-
low-up contained all of the cytohistological tests performed on 
the seven cohorts over a twelve-month period, with the purpose 
of determining the significance of inadequate results. 
Loss of follow-up was defined as absence of cytological or 
histological tests over the 12-month period. In this study, 1,262 
women (49.5%) were lost from follow-up visits. These women 
did not undergo repetition of the inadequate Pap test at the 
end of the three-month period that was recommended by the 
Ministry of Health. 
For data analysis, an Excel template was used. Descriptive 
statistics were calculated: mean, minimum and maximum, and 
relative frequency. A tracking tree, the “conditional probabil-
ity tree diagram”, was used to identify the number, type, result, 
and time interval between the tests on these patients. The first 
row symbolized the first inadequate result. The second, third and 
fourth rows were the tests taken after the inadequate result.
RESULTS
The women’s mean age was 39.1 years, with a minimum age 
of 17  years and a maximum of 84 years. The Cervical Cancer 
Program covers the group of women aged 25 to 64 years, which 
included 2,361 women (92.7%). 
The requirement, set by the Ministry of Health, for repe-
tition of smears due to inadequate cytological data for deter-
mining a diagnostic conclusion, was applicable to 50.5% of 
the women (n = 1,285). The other 49.5% of the women did not 
undergo repetition of smear collection because of personal or 
technical reasons (n = 1,262). 
The re-administered cytological tests yielded the follow-
ing results: a cytological report of cervical atypia was given for 
8  women (0.6%); the repeated smear was also inadequate in 
the cases of 139 women (10.9%); a cervical lesion was detected 
in 34 women (2.6%); and normal results were reported in 
1,104 women (85.9%). 
Analysis on the inadequate results based on the specific 
cause was performed at the time of the follow-up visit of the 
cohorts of women using the conditional probability tree diagram. 
In Figure  1, the cytohistological follow-up on the cohort G0 (smears 
with endocervical cells alone) is represented. The first row repre-
sents the total number of women with a G0 Pap result (4 women). 
The second row shows that 3 of the 4 women did not repeat the Pap 
(LF), and one woman had a normal cytological result (negative). 
Figure 2 presents the cytohistological follow-up on the 
cohort G1 (insufficient sample). The first row represents the total 
number of women with a G1 Pap result (375). The second row 
shows that the majority (189) of the 375 women did not comply 
with the ministerial rule for retesting (LF). Among those who did 
have the Pap repeated (186), a normal cytological report (nega-
tive) was the most frequent result (171), followed by 12 inade-
quate reports (G1, G3, G6) and 3 cases of lesions, of which two 
were low grade (A and AL) and one was high grade (B). The third 
row shows that the cases with lesions required further examina-
tion, thus confirming the results in two cases. This cohort showed 
that additional cytological specimens were collected from women 
with normal and inadequate results, a situation that does not fall 
within the regulations of the Ministry of Health.
Figure 3 presents the cytohistological follow-up on the 
cohort G2 (hemorrhagic samples). The first row represents 
the total number of women with a G2 Pap result (249). In the sec-
ond row, the same trend as described in the previous cohorts was 
observed regarding the high proportion of women (112) who did 
not undergo a repeat cytological examination (LF). The follow-up 
tree shows that the most frequent outcome from the repeated exam-
inations was a normal result (negative) (123 women). In the cases of 
10 women, the inadequate results were repeated (G2, G3 and G6). 
There were four women (2.9%) with low (A and A1) and high-grade 
cervical lesions (C) with a cytological and histological follow-up for 
diagnosis and treatment that ultimately produced a normal cytologi-
cal result. In the third row, additional tests were carried out for those 
with normal and inadequate cytological and histological results, 
which were most likely indicated for clinical reasons (Figure 3). 
Figure 4 presents the cytohistological follow-up on the 
cohort G3 (inflammatory samples). The first row represents 
the total number of women with a G3 Pap result (1,427). In the 
second row, 684 women were lost from the follow-up (LF) 
(47.9%). A normal result (negative) predominated among the 
cytological results (630 women), followed by 79 cases in which 
Pap
LF
3
LF
4
GO
1
Neg
Cytological test.
Loss of follow-up.
Figure 1. Follow-up on women with a G0 smear report 
(2010-2011).
GO = smears with endocervical cells only; LF = loss of follow-up; 
Neg = negative for neoplastic cells.
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Figure 2. Follow-up on women with a G1 smear report (2010-2011).
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G1 = insufficient sample; LF = loss of follow-up; Neg = negative for neoplastic cells; G3 = inflammatory sample; G6 = insufficient and inflammatory sample;  
A = possible low-grade intraepithelial lesion; AL = possible low-grade intraepithelial lesion plus condyloma; B = possible high-grade intraepithelial lesion;  
G0 = smears with endocervical cells only; A1 = possible low-grade intraepithelial lesion plus HPV; BL = possible high-grade intraepithelial lesion plus condyloma.
Figure 3. Follow-up on women with a G2 smear report (2010-2011).
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G2 = hemorrhagic sample; LF = loss of follow-up; Neg = negative for neoplastic cells; G3 = inflammatory sample; G6 = insufficient and inflammatory sample; 
C = possible high-grade intraepithelial lesion or cancer (Ca) in situ; A = possible low grade intraepithelial lesion; A1 = possible low-grade intraepithelial lesion 
plus HPV, AL = possible low-grade intraepithelial lesion plus condyloma; BL = possible high-grade intraepithelial lesion plus condyloma;  
CL = possible high-grade intraepithelial lesion or Ca in situ plus condyloma; ASC-US = atypical squamous cells of undetermined significance.
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inadequate results (G) were obtained during the second Pap test. 
In eight patients, cervical lesions were detected through the cyto-
logical test. There were ten with low grade lesions (low), and six 
were detected by means of histology, corresponding to 3.2%. The 
// symbol represents a variety of diagnostic and treatment pro-
cedures. Finally, in the last row, 17 women still had inadequate 
reports (G3), 18 women were found to have low-grade lesions 
(low), and 13 were found to have high-grade lesions. 
Figure 5 presents the cytohistological follow-up on the 
cohort G4 (poor fixation). The first row represents the total num-
ber of women with a G4 Pap result (61). The second row shows 
that the majority (37) were lost from the follow-up (LF), while 
24 women complied with the requirement to repeat the cyto-
logical test. From these, most had normal results (negative) (21 
women), while two had inadequate results (G3 and G4) and one 
had a high-grade lesion (B) that required histological follow-up. 
Figure 6 presents the cohort G5 (insufficient and hemor-
rhagic samples). The first row represents the total number of 
women with a G5 Pap result (40). The second row shows that 
more than half did not repeat the test (LF) (23 women). Among 
the participants who re-took the test (17), most (15) had a nor-
mal result with no lesions.
Figure 7 presents the cohort G6 (insufficient and inflamma-
tory samples). The first row represents the total number of women 
with a G6 Pap result (391 women). The second row shows that 
the majority of the women (214) did not repeat the test (54.7%) 
(LF). Among those who repeated the test, 138 had normal results 
(negative), 35 had inadequate results, (G1, G2, G3, G4, G5 and 
G6), two women had atypical results (atypical and H2) and two 
women had low-grade lesions. The third row shows that addi-
tional tests were carried out for those with normal results. Two 
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Figure 4. Follow-up on women with a G3 smear report (2010-2011).
G3 = inflammatory sample; LF = loss of follow-up; Neg = negative for neoplastic cells; Atypical = includes ASCUS and ASC-H; G includes insufficient sample, 
hemorrhagic sample and inflammatory sample; low = includes possible low grade intraepithelial lesion alone, plus HPV and plus condyloma;  
high = includes possible high grade intraepithelial lesion alone, plus condyloma, cancer in situ and squamous carcinoma; ASC-US = atypical squamous  
cells of undetermined significance.
Figure 5. Follow-up on women with a G4 smear report 
(2010-2011).
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G4 = sample with poor fixation; LF = loss of follow-up; Neg = negative 
for neoplastic cells; G3 inflammatory sample; B = possible high-grade 
intraepithelial lesion; C = possible high grade intraepithelial lesion or 
Ca in situ; CL = possible high grade intraepithelial lesion or cancer in 
situ plus condyloma; ASC-H = atypical squamous cells, cannot exclude 
a high grade squamous intraepithelial lesion; 
AL = possible low grade intraepithelial lesion plus condyloma.
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women had a low-grade lesion (A and A1) and one had an atypi-
cal result (H2) that required cytohistological follow-up, which is 
represented in the subsequent rows.  
During the process of obtaining a conclusive diagnosis, a 
total of 4,169 tests were performed, which included 4,066 smears 
and 103 biopsies, resulting in an average of 1.6 tests per woman. 
There were 254 tests that had to be repeated and were not 
justified by the regulations of the Ministry of Health, i.e. those 
with normal results and those that had an inadequate result for 
the second time.
The probability of observing a cervical lesion with a repeat 
test according to the ministerial rule ranged from 1.1% (G6) to 
4.1%. Cohorts G2, G3 and G4 showed the highest probabilities 
of lesions (2.9%, 3.2% and 4.1%, respectively). The G0 and G5 
cohorts did not show any cytopathological lesions.
Our results relating to each cohort show that compliance 
with the ministerial rule allowed women with cervical lesions to 
have access to healthcare in accordance with the clinical protocol, 
which enabled them to have a good outcome for their pathologi-
cal condition, especially women with inadequate results due to 
hemorrhagic or inflammatory samples.
DISCUSSION
In our study on the outcomes from inadequate smears, three 
important findings were identified that relate to the fol-
lowing: i) low compliance with the ministerial regulation 
with regard to repetition of inadequate smears (one in two 
women); ii) high detection of normality in repeated reports 
from women who provided inadequate smears (nine out of 
ten); and iii) increased probability of lesions in women whose 
first smear was inadequate for hemorrhagic and inflamma-
tory reasons.
We found that compliance with the recommendation for rep-
etition of inadequate smears was deficient. This was similar to 
the findings from another study reported by the Cervical Cancer 
Screening Program in Ontario, Canada, in which only 35% of the 
women who had an inadequate Pap test repeated it within 
the recommended period of four months.9
Cytological test.
Loss of follow-up.
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LF
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40
G5
23
LF
1
Neg
15
Neg
1
ASC-US
Figure 6. Follow-up on women with a G5 smear report 
(2010-2011).
G5 = insufficient and hemorrhagic sample; LF = loss of follow-up;  
Neg = negative for neoplastic cells; ASC-US = atypical squamous cells  
of undetermined significance; G2 = hemorrhagic sample.
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Figure 7. Follow-up on women with a G6 smear report (2010-2011).
G6 = insufficient and inflammatory sample; LF = loss of follow-up; Neg = negative for neoplastic cells; G1 = insufficient sample; G2 = hemorrhagic sample; 
G3 = inflammatory sample; G4 = poor fixation sample; G5 = insufficient and hemorrhagic sample; G6 = insufficient and inflammatory sample;  
ASC-US= atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells, cannot exclude a high grade squamous intraepithelial 
lesion; A = possible low grade intraepithelial lesion; A1 = possible low grade intraepithelial lesion plus HPV; B = possible high grade intraepithelial lesion;  
BL = possible high grade intraepithelial lesion plus condyloma; AL = possible low grade intraepithelial lesion plus condyloma.
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Our study provides evidence that in nine out of ten cases, 
an inadequate result will be normal after the repetition of 
the test. Other studies have also reported similar findings. 
Adams et al. in the United States conducted a case-control 
study on inadequate and satisfactory smears, based on the 
Bethesda 2001 criteria, with a follow-up from 1998 to 2004 
(including 167 patients with inadequate Pap tests and 350 
with normal results). No significant differences were found 
between the adequate and inadequate smears with regard to 
the prevalence of cervical lesion detection.7 Furthermore, in a 
study evaluating a cervical cancer screening program in South 
Africa using a controlled clinical essay with patients recruited 
from 2003 to 2005, the incidence of cervical cytological abnor-
malities in women with previous normal smears was 6.48%, 
and it was 11.71% among those with inadequate smears. 
It was concluded that the incidence of high-grade lesions was low 
after repeating a normal or inadequate smear two years later.10 
In the Netherlands, through a controlled clinical trial using 
data from the NETHCON clinical database of women from the 
Cervical Cancer Screening Program, the clinical relevance of 
an unsatisfactory Pap test was evaluated with a cytohistological 
follow-up period of 18 months. It was found that 0.7 and 0.8% of 
the samples from liquid-based and conventional cervical smear 
collections presented high-grade lesions.11 Different findings 
were obtained in a prospective study conducted in Norway over 
the period 1995-2001. The authors concluded, after two years 
of follow-up, that the risk of detection of high-grade lesions in 
women with an unsatisfactory Pap test was 1.6 to 4.0 times higher 
than in women with a normal Pap.12
Considering the existing scientific data as well as the cur-
rent study, it is possible to justify the need for revision of 
the current clinical guidelines in Chile regarding repetition 
of inadequate cytological tests after a three-month period. 
Furthermore, as Gavranovic et al. showed, repetition of inadequate 
smears adds economic and social costs to the healthcare program 
without significantly increasing the lesion detection rate.13
This need for revision is already being considered on in the 
United States, where the American Society for Colposcopy and 
Cervical Pathology began the process of revising the 2006 clini-
cal guidelines on inadequate handling of Pap tests, at a meeting 
that took place on September 14 and 15, 2012.14
CONCLUSIONS
•	 In 2010, 5.84% of Papanicolaou tests (2,779/47,541) resulted 
in inadequate smears in the southern metropolitan area of 
Santiago, Chile.
•	 50.5% of these women (n = 1,285) had a repeat test after 
an inadequate smear, but only 23.6% (304/1,285) complied 
with the ministerial regulation, i.e. they repeated the test 
within a three-month period.
•	 After obtaining the second Pap test, it was found that 85.9% of 
the women had normal smears (1,104/1,285); 0.6% obtained 
cytological reports of cervical atypia (n = 8 women); 10.9% 
had a repeat test after an inadequate smear (n = 139 women); 
1.6% had a low-grade cervical lesion (n = 21 women); and 
1.0% had a high-grade lesion (n = 13 women).
•	 The results from this study justify revision of the current 
clinical guidelines in Chile regarding repetition of tests 
that provide inadequate cervical cytological data for any of 
the reasons considered within a three-month period. It is 
important to address the causes of inadequate smears and to 
repeat the test only in cases of hemorrhagic and inflamma-
tory cytological results.
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